Formosa Laboratories Inc
TWSE:4746
Formosa Laboratories Inc
Other Equity
Formosa Laboratories Inc
Other Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Formosa Laboratories Inc
TWSE:4746
|
Other Equity
-NT$15.3m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-47%
|
CAGR 10-Years
N/A
|
|
|
Y
|
YungShin Global Holding Corp
TWSE:3705
|
Other Equity
-NT$270.4m
|
CAGR 3-Years
12%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-28%
|
|
|
ScinoPharm Taiwan Ltd
TWSE:1789
|
Other Equity
-NT$28.6m
|
CAGR 3-Years
29%
|
CAGR 5-Years
22%
|
CAGR 10-Years
N/A
|
|
|
S
|
SCI Pharmtech Inc
TWSE:4119
|
Other Equity
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Lotus Pharmaceutical Co Ltd
TWSE:1795
|
Other Equity
-NT$1.4B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
N/A
|
|
|
Standard Chem & Pharm Co Ltd
TWSE:1720
|
Other Equity
NT$4.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-32%
|
|
Formosa Laboratories Inc
Glance View
Formosa Laboratories, Inc. engages in the research and development of biotechnology new drugs. The company is headquartered in Taoyuan, Taoyuan. The company went IPO on 2009-11-27. The firm primarily provides UV-proof active ingredients series products, vitamin D derivative series products, anti-inflammatory analgesic series products, steroid, anti-cancer drugs, cholesterol phosphate binding agents, nuclear magnetic resonance (NMR) reagents, respiratory disease drugs, central nervous system drugs, immune system regulators and weight loss drugs, as well as customized research and development and original equipment manufacturing (OEM) services. The firm distributes its products to Europe, the Americas, Asia and other markets.
See Also
What is Formosa Laboratories Inc's Other Equity?
Other Equity
-15.3m
TWD
Based on the financial report for Dec 31, 2024, Formosa Laboratories Inc's Other Equity amounts to -15.3m TWD.
What is Formosa Laboratories Inc's Other Equity growth rate?
Other Equity CAGR 5Y
-47%
Over the last year, the Other Equity growth was -12%. The average annual Other Equity growth rates for Formosa Laboratories Inc have been -21% over the past three years , -47% over the past five years .
You don't have any saved screeners yet